Artificial Intelligence Enhanced Detection of Hospitalized Dyskalemia

Overview

About this study

The purpose of this study is to prospectively demonstrate that implementation of AI-ECG directed monitoring for the effective treatment of dyskalemia (both hyper- and hypokalemia) in acutely ill, hospitalized patients will serve the following purposes:

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria: 

  • Age ≥ 18 years and able to provide consent (for prospective portion).

Exclusion Criteria:

  • Patients under age 18 and patients unable to provide consent.

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 8/8/23. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Jacob Jentzer, M.D.

Closed for enrollment

Contact information:

Jennifer Dugan

(507) 538-1125

Dugan.Jennifer@mayo.edu

More information

Publications

Publications are currently not available